BridgeBio Pharma, Sentynl Therapeutics receive marketing authorization in the EU for fosdenopterin
NULIBRY is a first-in-class cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A.
NULIBRY is a first-in-class cPMP substrate replacement therapy to reduce the risk of mortality in patients with MoCD Type A.
Dolomite Bio scientist demonstrating pipetting into the Nadia Go
The campaign will also focus on providing doorstep TB screening services to facilitate diagnosis
Sitagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus
Despite the technological advancements, there remains no alternative to blood and one unit of blood can save as many as three lives
The #pledgemyeyes initiative reached out to over 30 million people across the country and the website registered 3X more pledges compared to the present numbers
He has over two decades of rich experience in management consulting, advising and transforming leading generic pharmaceutical companies in India and global markets
This will give a boost to cost-effective, quality medicines and contribute towards reduction in out of pocket expenditure on healthcare for the citizens
The programme will see participation from various ministries of the Government of India with the aim of 3Js – Jan Sandesh, Jan Bhagidari, and Jan Aandolan.
Despite having rich knowledge and defined responsibility, there has been less than expected response towards organ donation from our citizens
Subscribe To Our Newsletter & Stay Updated